Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Nicotine analogues proposed for treatment of depression

Nov. 8, 1996

Risperidone + clozapine effective in chronic schizophrenia

Nov. 8, 1996

New treatment option for schizophrenia approved in Canada

Nov. 8, 1996

Scotia schizophrenia project develops rapidly

Nov. 8, 1996

5-HT1A receptor agonists from Sankyo

Nov. 8, 1996

Yoshitomi describes compounds for anxiety and epilepsy

Nov. 8, 1996

Migraine-related gene discovered by Dutch researchers

Nov. 8, 1996

Focus on present and future migraine therapy

Nov. 8, 1996

Menarini receives U.S. patent coverage for single-isomer analgesic

Nov. 8, 1996

Lilly reports 5-HT1F agonists for migraine

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.